SUPER
  1. Home
  2. Stocks
  3. IBLHL
  4. News and notes

IBLHL · PHARMACEUTICALS

IBLHL news and notes IBL HealthCare Limited

IBL HealthCare Limited (IBLHL) news and notes: the SuperX note and what changed (3 items). The note is written by SuperX’s AI from its own figures. What changed is listed newest first.

What SuperX wrote about IBLHL

  1. The price fell 0.05% on 13 Nov. The pharmaceuticals sector median fell 0.2% this session.

  2. The half-year period ends 31 Dec. Last year the company filed its half-year results on 24 Feb.

  3. The latest quarter's EPS fell from 0.71 to 0.65 PKR, down 8.45%. The price fell 1.63% on the results day, 29 Oct.

Written by SuperX’s analyst desk from SuperX’s own figures, from the close of 13 Nov 2026. Each number was checked against those figures. Not advice.

What changed for IBLHL, newest first

  • 13 Nov 2026Closed 40.83, -0.05%. Volume 21,694, 0.3 times the average of the 30 sessions before it, 86,562.
  • 29 Oct 2026Quarter ended 30 Sep 2026: earnings per share Rs 0.65, sales Rs 1.1 bn, down 8.5% on the same quarter a year before.
  • NextHalf-year results (to 31 Dec 2026) expected 19 Feb 2027 – 1 Mar 2027, a projection. An estimate from the dates of the last 8 filings.

As of the close of 13 Nov 2026. Closes and notices: PSX. Volume: against the average of the 30 sessions before the last. Next results: an estimate from the dates of the last 8 filings. Not advice.

More on IBLHL

Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .